Skip to content
Solar Royal Network

Users Stopping Weight-Loss Injections Gain Back Weight at a Quadrupled Rate Compared to People Using Diet and Exercise

Illustration of medical injection and weighing machine
Obesity treatment involves ongoing approaches.

Fresh analysis indicates that people who come off popular GLP-1 drugs like semaglutide or tirzepatide can put back on lost weight much more quickly than those who stop conventional diet and exercise regimens.

Research printed in a major health publication points out that while obese individuals often shed about a fifth of their body weight while undergoing treatment, the mass is regained at an average rate of nearly a kilo each month once they quit.

"People buying these treatments need to be aware of the potential of fast rebound weight gain when the treatment is stopped," warns researcher Dr. Susan Jebb.

That rate of regain suggests a reversion to pre-treatment mass within about a year and a half.

Weighing Treatments

The analysis, which looked at dozens of studies involving thousands of patients, compared the results of GLP-1 agonists with conventional dieting.

Researchers emphasize that people who shed pounds through lifestyle changes alone generally experience a more gradual creep back—perhaps 100 grams monthly—once they finish.

The Reason for the Rapid Regain

Experts propose the mode of action of the drugs explains the accelerated rebound.

These medications mimic a body's own chemical called glucagon-like peptide-1, which helps regulate appetite.

"Long-term administration of the hormone levels several times higher than the body's typical production may cause the system to generate a reduced amount of its endogenous GLP-1, and could reduce responsiveness to its effects," noted Dr. Adam Collins, a nutrition specialist.

"Discontinuation of this GLP-1 'fix' leads to appetite is unsuppressed, making excessive eating much more probable."

A Chronic Condition?

Medical guidelines recommend the jabs for individuals with obesity-related medical conditions, alongside recommended lifestyle changes.

A number of clinicians say that, due to the high risk of relapse, the therapy might need to be long-term.

This view is reinforced by pharmaceutical companies, who note that the results "highlight the chronic nature of excess weight," akin to managing diseases like diabetes.

User Accounts

People who have discontinued the medication describe a intense return of cravings.

"It was like a switch that goes on and you're instantly starving," said an individual.

This challenge is exacerbated if patients have not adopted sustainable dietary or behavioural changes during treatment.

Growing Adoption

Recent estimates indicate that millions of adults in the UK have tried these injections in the last 12 months, with desire continuing to grow.

  • Use is greater among females than males.
  • The middle-aged demographic shows the greatest level of interest.
  • A large proportion obtain the drugs through private prescriptions rather than public health services.

In conclusion, experts stress that while these medications are potent tools for shedding pounds, they are not a permanent fix and lasting health benefits relies on integrated lifestyle changes.

The writer

Aaron Dunlap

Renewable energy consultant with over a decade of experience in solar technology and sustainable development projects worldwide.

Solar Royal Network

Type to search articles.